Cancer Disparities: One of the Most Pressing Public Health Issues medscape.com/viewarticle/93…

That says it all then doesn’t it

First CAR T-cell Tx for Mantle Cell Lymphoma Fills Unmet Need medscape.com/viewarticle/94…

FDA approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment. fda.gov/news-events/pr…

Very sad to learn of the passing of Dr José Baselga today. The entire oncology drug development community mourns the loss of a fundamental element in the war on cancer.

[New eBook] CAR T-cell Therapy in Hematological Malignancies: Staying Ahead of a Rapidly Evolving Landscape. Get the eBook now to leverage the lessons learned in a decade of innovation and impact the next revolution in cancer immunotherapy. Download today: hubs.ly/H0JSmNJ0

Don't miss today's Precision webinar exploring the clinical significance of the tumor microenvironment and complexities of tumor spatial profiling. Wednesday, March 31 at 12pm EDT. Register here: lnkd.in/dQEHuM6

Attempts to use macrophages as a cell therapy have largely failed due to cancerous tumors' ability to "trick" them into being pro-cancer. Wyss researchers have created a cell therapy innovation that keeps macrophages activated against cancer. wyss.harvard.edu/technology/cel…

Attending #ASGCT2021 next month? Don't miss our 2-part panel discussion with biotech executives on the front lines of development and our Precision experts. Tuesday, May 11, 2021: Cell Therapy, Part 1, 5:15-6:00 ET, and Gene Therapy, Part 2, 6:00-6:45 ET.

Precision's Megan Liles offers 5 actionable steps to making clinical trials more patient-centric. informaconnect.com/5-ways-patient…

“Watch out for drug-pricing headlines this week” - Brad Loncar ending up this week’s review with a quick prediction!

Roberto Lara Biotech Hangout I left 2021 YTD out as it would look strange on the charts (low M&A volume so far). Looks similar to 2020 with 70% prior to an approved product and about 50% Phase I and earlier

I pick the #GoHabsGo to win Game 6. Watch tonight at 8ET! #StanleyCup

#GoHabsGo

Sharp Increase in Cancer Incidence and Mortality From 2020-2040 medscape.com/viewarticle/95…

CDER Pilot Program Offers Potential New Pathway For Approval Of Novel Pharmaceutical Excipients pink.pharmaintelligence.informa.com/PS144995/CDER%…

Once hockey's most sought-after coach, has Mike Babcock learned anything after his fall from grace? BIG READ 📚 | ✍️: David Singh sportsnet.ca/nhl/longform/i…